The Relationship Between Osteoporosis and Phenotypic Heterogeneity in COPD
骨质疏松症与慢性阻塞性肺病表型异质性的关系
基本信息
- 批准号:7643624
- 负责人:
- 金额:$ 13.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-01 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:AlgorithmsAntibodiesAttenuatedBioinformaticsBiological FactorsBiological MarkersBiological Response Modifier TherapyBiometryBlocking AntibodiesBody mass indexBone DensityBone DiseasesBone MarrowBone ResorptionCategoriesCell CountCell Culture TechniquesChronicChronic Obstructive Airway DiseaseClassificationClinicalClinical TrialsCollaborationsCoronary ArteriosclerosisCross-Sectional StudiesDentinDevelopmentDirect CostsDisciplineDiseaseDisease ProgressionEnsureEnvironmentEpidemiologyEvaluationEvolutionFacilities and Administrative CostsFractureFrequenciesFunctional disorderFutureGonadal HormonesHeterogeneityHip region structureIndividualInflammationInflammation MediatorsInflammatoryInterleukin-6LaboratoriesLeadLearningLinkLiteratureLongitudinal StudiesLungMeasurementMeasuresMediator of activation proteinMedicalMentorsModelingMonitorMononuclearMorbidity - disease rateMultiple MyelomaNatural HistoryNatureObstructionOralOsteoclastsOsteogenesisOsteoporosisOutcome AssessmentPatientsPatternPeripheralPeripheral Blood Mononuclear CellPhenotypePhysiologicalPrevalencePrincipal InvestigatorProcessPulmonary EmphysemaPulmonary Function Test/Forced Expiratory Volume 1ResearchResearch PersonnelResourcesRiskRisk FactorsScreening procedureSeriesSerumSerum MarkersSeveritiesSkeletal MuscleSkeletal systemSmokerSteroid therapySteroidsSubgroupTechniquesTestingTherapeuticTimeTrainingTumor Necrosis Factor-alphaUnited StatesUniversitiesVariantVertebral columnabstractingauthoritybasebone lossbone metabolismburden of illnesscigarette smokingclinical phenotypecohortdisease phenotypedriving forceexperiencehormone deficiencyinflammatory markerinsightknowledge basemortalityprecursor cellresearch studyskillssymposiumtime interval
项目摘要
DESCRIPTION (provided by applicant): Studies show an increased prevalence of osteoporosis in individuals with chronic obstructive pulmonary disease (COPD), yet an understanding of the true prevalence, clinical implications, and mechanistic relationships remains limited. This proposal will determine the prevalence of decreased bone mineral density (BMD) and accelerated loss of BMD over time and its relationship to markers of bone resorption and formation within spirometrically defined categories of obstruction severity in a large cohort of current and former smokers with wide variability of airflow limitation. Radiographic, clinical, and serum marker phenotypes will be used to construct a classification and prediction model to identify COPD patients at greatest risk for osteoporosis and accelerated loss of BMD over time. Finally, a set of translational experiments will compare osteoclast formation and activity and its relationship to serum inflammatory mediators in COPD patients with and without decreased BMD and accelerated loss of BMD over time. These aims will define the COPD phenotype that should undergo osteoporosis screening, provide insight into the underlying mechanisms relating COPD and osteoporosis, and identify possible targets for screening and therapy. Training Plan: This proposal will provide the candidate with the unique opportunity to cross medical disciplines, expanding her COPD knowledge-base while developing a background in osteoporosis and bone metabolism. Through coursework and conferences, the candidate will acquire advanced training in biostatistics, epidemiology, and bioinformatics. Techniques learned in Dr. Roodman's laboratory through implementation of this proposal will equip the candidate with the skills necessary to communicate effectively during translational collaborations. The resources and experience of mentor Dr. Sciurba, an expert in COP clinical phenotyping and outcome assessment in clinical trials, and co-mentor Dr. Roodman, an authority on multiple myeloma and bone disease, combined with the robust research environment at the University of Pittsburgh, ensure the candidate's successful evolution to an independent investigator. (End of Abstract)
描述(由申请人提供):研究表明慢性阻塞性肺疾病(COPD)患者骨质疏松症的患病率增加,但对真实患病率、临床意义和机制关系的理解仍然有限。本提案将在一个大型队列中确定骨矿物质密度(BMD)降低和BMD随时间加速丢失的患病率,以及其与肺量计定义的阻塞严重程度类别内的骨吸收和形成标志物的关系,该队列中的当前和既往吸烟者具有广泛的气流限制变异性。影像学、临床和血清标志物表型将用于构建分类和预测模型,以识别骨质疏松症风险最高和BMD随时间加速丢失的COPD患者。最后,一组转化实验将比较破骨细胞形成和活性及其与COPD患者血清炎症介质的关系,这些患者有和没有BMD降低和BMD随时间的加速损失。这些目标将定义应接受骨质疏松症筛查的COPD表型,深入了解COPD和骨质疏松症相关的潜在机制,并确定筛查和治疗的可能靶点。培训计划:该提案将为候选人提供跨医学学科的独特机会,扩大她的COPD知识基础,同时发展骨质疏松症和骨代谢的背景。通过课程和会议,候选人将获得生物统计学,流行病学和生物信息学的高级培训。通过实施本提案,在Roodman博士的实验室学到的技术将使候选人具备在翻译合作期间有效沟通所需的技能。导师Sciurba博士是COP临床表型和临床试验结果评估方面的专家,共同导师Roodman博士是多发性骨髓瘤和骨病方面的权威,其资源和经验与匹兹堡大学强大的研究环境相结合,确保候选人成功发展为独立研究者。 (End摘要)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JESSICA BON其他文献
JESSICA BON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JESSICA BON', 18)}}的其他基金
Fungal Translocation in Chronic Obstructive Pulmonary Disease
慢性阻塞性肺疾病中的真菌移位
- 批准号:
10610446 - 财政年份:2022
- 资助金额:
$ 13.03万 - 项目类别:
Fungal Translocation in Chronic Obstructive Pulmonary Disease
慢性阻塞性肺疾病中的真菌移位
- 批准号:
10434243 - 财政年份:2022
- 资助金额:
$ 13.03万 - 项目类别:
Pittsburgh Innovation in Collaborative Training of Residents Alliance
匹兹堡居民联盟协作培训创新
- 批准号:
10608088 - 财政年份:2020
- 资助金额:
$ 13.03万 - 项目类别:
Pittsburgh Innovation in Collaborative Training of Residents Alliance
匹兹堡居民联盟协作培训创新
- 批准号:
10350563 - 财政年份:2020
- 资助金额:
$ 13.03万 - 项目类别:
The impact of a home-based pulmonary telerehabilitation program on muscle function and quality of life following acute exacerbations of chronic obstructive pulmonary disease
家庭肺远程康复计划对慢性阻塞性肺疾病急性加重后肌肉功能和生活质量的影响
- 批准号:
10201778 - 财政年份:2019
- 资助金额:
$ 13.03万 - 项目类别:
Autoimmunity and emphysema and risk of osteoporosis in smokers
吸烟者的自身免疫和肺气肿以及骨质疏松症的风险
- 批准号:
9916794 - 财政年份:2016
- 资助金额:
$ 13.03万 - 项目类别:
Emphysema and Inflammatory Biomarkers and Risk of Osteoporosis in Men with COPD
肺气肿和炎症生物标志物以及男性慢性阻塞性肺病患者骨质疏松症的风险
- 批准号:
9551566 - 财政年份:2015
- 资助金额:
$ 13.03万 - 项目类别:
Emphysema and Inflammatory Biomarkers and Risk of Osteoporosis in Men with COPD
肺气肿和炎症生物标志物以及男性慢性阻塞性肺病患者骨质疏松症的风险
- 批准号:
9932924 - 财政年份:2015
- 资助金额:
$ 13.03万 - 项目类别:
Emphysema and Inflammatory Biomarkers and Risk of Osteoporosis in Men with COPD
肺气肿和炎症生物标志物以及男性慢性阻塞性肺病患者骨质疏松症的风险
- 批准号:
9337253 - 财政年份:2015
- 资助金额:
$ 13.03万 - 项目类别:
The Relationship Between Osteoporosis and Phenotypic Heterogeneity in COPD
骨质疏松症与慢性阻塞性肺病表型异质性的关系
- 批准号:
7903213 - 财政年份:2009
- 资助金额:
$ 13.03万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 13.03万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 13.03万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 13.03万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 13.03万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 13.03万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 13.03万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 13.03万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 13.03万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 13.03万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 13.03万 - 项目类别: